KMC Systems, a medical diagnostics manufacturer that supplies instruments to many of the largest in vitro diagnostics companies in the world, spent 2020 building solutions and creating results for patients.
This year, instruments that KMC built helped its customers install 1 billion in capital test capacity – enough tests for nearly one seventh of the entire world’s population. Those instruments test patient samples for a wide range of illnesses, including the coronavirus, Influenza A and B, HIV, HPV, HCV, Chlamydia, Gonorrhea, Trichomoniasis, Mycoplasma Genitalium, Respiratory Syncytial Virus, Antiphospholipid Syndrome, Connective Tissue Disease, Celiac Disease, Inflammatory Bowel Disease, Autoimmune Liver Disease, Rheumatoid Arthritis, Vasculitis, bacterial infections, blood-borne pathogens and allergies.
Addressing the Growing Need
As COVID-19 began to dominate the American healthcare agenda in the spring and summer months, KMC ramped up its production capacity to meet a growing need for coronavirus testing equipment. The company increased its manufacturing levels to historic highs, delivering instruments that provided hundreds of millions of screens to patients across the country and around the world.
In order to accomplish that, KMC created many new jobs, increasing its workforce by 11%. KMC continues to seek talented new staffers in manufacturing, quality, supply chain, engineering and business development.
KMC also helped design and obtain federal approval for three of its customers’ new instruments, which are now scheduled to go into production in 2021. Those machines join a growing list of KMC products saving lives globally, including one which next year is projected to test over half of the women in Holland and Germany for cervical cancer.
In 2020, KMC paired its groundbreaking collaboration alongside its customers with continued efforts to streamline workflows within its eight internal departments. The organization also enacted a five-year strategic plan and leadership team charter to guide its action in the years ahead.
In a year that found Americans further apart – physically – than ever before, KMC worked to reach out and enrich the local community. The company and its corporate parent, Elbit America, proudly carried on their annual tradition of sponsoring the Leukemia and Lymphoma Society, raising more than $188,000 in 2020 alone.
KMC employees also participated in “Light the Night,” an evening walk with lights to promote cancer awareness and fundraise for a cure.
This year, KMC also collaborated with Manchester and Nashua Community Colleges to bring professional programming to students, highlighting KMC’s life-saving work and how those pupils can become a part of KMC’s mission. Several students have already followed in their alumni’s footsteps and investigated opportunities on KMC’s manufacturing floors.
With 2021 now well underway, KMC looks forward to working with its employees, supply chain partners and customers to build a better tomorrow, together.